Sage Journals: Discover world-class research

Retricted access

Research article

First published 1988-10

Trend of Spontaneous Reports Containing Selected Adverse Drug/Biologic Reactions: 1970–1986

Deanne E. Knapp, Zollie A. Perry

Therapeutic Innovation & Regulatory Science

Open access

Review article

First published 2017

Use of Biomedical Ontologies for Integration of Biological Knowledge for Learning and Prediction of Adverse Drug Reactions

Shadia Zaman, Sirarat Sarntivijai, Darrell R Abernethy

Gene Regulation and Systems Biology

Retricted access

Case report

First published 2009-5

Anaphylactic Reaction to Anakinra in a Rheumatoid Arthritis Patient Intolerant to Multiple Nonbiologic and Biologic Disease-Modifying Antirheumatic Drugs

Ditina Desai, Raphaela Goldbach-Mansky, Joshua D Milner [...]

Annals of Pharmacotherapy

Retricted access

Letter

First published 2022-9

Onset of Sarcoidosis in Patients on Biologic Therapy: A Systematic Review

Yuliya Lytvyn, Asfandyar Mufti, Muskaan Sachdeva [...]

Journal of Cutaneous Medicine and Surgery

Retricted access

Research article

First published 2025-1

Postmarketing Analysis of Eosinophilic Adverse Reactions in the use of Biologic Therapies for Type 2 Inflammatory Conditions

Dafna Gershnabel Milk, Kent K. Lam, Joseph K. Han

American Journal of Rhinology & Allergy

Open access

Case report

First published 2022

Severe Immediate and Delayed Hypersensitivity Reactions to Biologics in a Toddler With Systemic Juvenile Idiopathic Arthritis

D. Sofia Villacis-Nunez, Kassahun Bilcha, Mary Spraker [...]

Journal of Investigative Medicine High Impact Case Reports

Retricted access

Other

First published 1985-7

Management of ADR Reports at the FDA

Charles Anello

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2016-3

Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings Highlights

Teresa Rubio

Hospital Pharmacy

Retricted access

Research article

First published 2016-6

Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings Highlights

Hospital Pharmacy

Retricted access

Research article

First published 2011-2

An approach to natalizumab hypersensitivity: a case series of induction of tolerance

Marie Camacho-Halili, Roxanne George, Malcolm Gottesman [...]

Multiple Sclerosis Journal

Search results